[1]
“Determination of the smallest detectable change (SDC) and the minimal important difference (MID) for the Small Fiber Neuropathy Screening List (SFNSL) in sarcoidosis: Interpretability of the SFNSL”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 35, no. 4, pp. 333–341, Nov. 2018, doi: 10.36141/svdld.v35i4.7260.